Entero Therapeutics
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-20.58-8.20-2.11-3.55-1.38-1.53-0.84-0.22-0.30-0.08N/A-1.45
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
18.40K-13.41K9.5914.434.175.05K-10.44-1.641.600.35N/A2.52K
Price/Cash Flow ratio
-48.08K-11.67K-6.79-5.48-1.71-1.66K-2.45-0.39-0.19-0.10N/A-831.82
Price/Free Cash Flow ratio
-40.45K-11.60K-6.78-5.46-1.67-611.63-2.45-0.30-0.19-0.09N/A-306.65
Price/Earnings Growth ratio
N/A-0.05-0.000.060.080.06-0.000.000.000.00N/A0.07
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
19.88%N/AN/AN/AN/AN/A-46.25%-45.30%-0.86%N/AN/AN/A
Return on Assets
-35967.71%-88700.53%-216.04%-169.39%-181.18%-170480.63%-252.79%-496.50%-268.94%-229.47%N/A-85330.90%
Return On Equity
-89423.03%163375.03%-454.14%-406.21%-302.50%-328717.43%1237.23%748.41%-533.50%-438.39%N/A-164509.96%
Return on Capital Employed
-70.35%222.02%-0.15%-0.24%-0.29%-319.31%1008.28%11570.43%-428.86%-420.56%N/A-159.80%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Quick Ratio
0.270.231.260.781.60616.170.420.760.581.58N/A308.88
Cash ratio
0.030.060.750.230.370.040.380.670.541.18N/A0.20
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/A-985.29801.61N/A6.71KN/AN/A-492.64
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/A532.89761.531.00K828.24996.041.83K2.47K6.91KN/A917.47
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
160.02983.790.020.060.03170.870.040.050.110.08N/A85.45
Debt Equity Ratio
397.85-1.81K0.040.150.05329.48-0.20-0.080.220.17N/A164.76
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
0.991.000.040.130.050.99-0.26-0.080.180.14N/A0.52
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
-0.00-0.00-29.22-17.24-42.61-0.00-20.31-50.35-37.02-20.19N/A-21.31
Company Equity Multiplier
2.48-1.842.102.391.661.92-4.89-1.501.981.91N/A1.79
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.181.001.001.001.022.711.001.3111.04N/A1.87
Cash Flow Coverage Ratio
-0.00-0.00-29.22-17.24-42.61-0.00-20.31-50.35-37.02-20.19N/A-21.31
Short Term Coverage Ratio
-0.00-0.00-29.22-17.24-42.61-0.00-20.31-50.35-37.02-20.19N/A-21.31
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A